Stueland Katherine bought WGS
January 29, 2026 · Form 4 insider transaction
Stueland Katherine bought 3,874 shares of GeneDx Holdings Corp. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,874
Price
$0.00
Total value
N/A
InsiderStueland Katherine
RoleOfficer, Director
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock
Transaction codeM: Option exercise
Transaction dateJanuary 29, 2026
Filing dateFebruary 2, 2026
Shares owned after18,111
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.